Comparison of the Intraocular Pressure-Lowering Efficacy and Safety of the Brinzolamide/Brimonidine Fixed-Dose Combination versus Concomitant Use of Brinzolamide and Brimonidine for Management of Open-Angle Glaucoma or Ocular Hypertension

OBJECTIVE: To demonstrate that the intraocular pressure (IOP)-lowering efficacy of a twice-daily brinzolamide 10 mg/mL (BRINZ)/brimonidine 2 mg/mL (BRIM) fixed-dose combination (BBFC) was non-inferior to its individual components (BRINZ+BRIM) dosed concomitantly in patients with open-angle glaucoma...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Ophthalmol
Hlavní autoři: Wang, Ningli, Lu, Da-Wen, Pan, Yingzi, Astakhov, Yury, Iureva, Tatyana, Adewale, Adeniyi, Walker, Thomas M
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove 2020
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6986681/
https://ncbi.nlm.nih.gov/pubmed/32158181
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S231402
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky